Secondary (predefined cost-effectiveness) analysis of a randomised trial in 268 patients with resectable neoplasm: robotic vs open pancreatoduodenectomy showed no significant difference in 6-month hospital costs (€30,956 vs €28,271); <30% probability robotic was cost-effective.
RCTn = 268
Menso et al. Cost-effectiveness Analysis of Robotic Versus Open Pancreatoduodenectomy (DIPLOMA-2): A Multicenter International Randomized Trial